Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE: 002755)

Market Cap	10.14B
Revenue (ttm)	1.65B
Net Income (ttm)	85.52M
Shares Out	928.16M
EPS (ttm)	0.09
PE Ratio	119.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,873,799
Open	10.88
Previous Close	10.81
Day's Range	10.66 - 10.99
52-Week Range	6.50 - 12.28
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Beijing Aosaikang Pharmaceutical

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 979
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002755

Financial Performance

In 2023, Beijing Aosaikang Pharmaceutical's revenue was 1.44 billion, a decrease of -22.92% compared to the previous year's 1.87 billion. Losses were -148.53 million, -34.23% less than in 2022.